Technology Review - Published By MIT
Advertisement
[1] 2 Next »

Tuesday, November 06, 2007

How a Tumor Is Like an Embryo

Pioneering cancer researcher Robert Weinberg says that deadly secondary tumors happen when cancer cells don't act their age.

By Katherine Bourzac

smaller text tool iconmedium text tool iconlarger text tool icon
Telltale tumors: Robert Weinberg (bottom) of the Whitehead Institute led a team of researchers that developed a method for transforming normal breast cells into aggressive cancer cells (top, stained green). All the cells pictured are cancer cells; as many as one in ten of them are cancer stem cells. Such cells cause the secondary tumors that kill 90 percent of cancer patients. Weinberg is using these cells to study how the tumors form.
Credit: Tan Ince (top), Sam Ogden/Whitehead Institute (bottom)
Multimedia
•  Robert Weinberg describes his research.

Thirty years ago, cancer was a black box. Researchers knew what went wrong in the body, but not how or why. The work of Robert Weinberg, professor of biology at MIT and a founding member of the Whitehead Institute for Biomedical Research, has helped researchers open that box. Weinberg discovered the first cancer-causing gene and the first tumor-suppressing gene in the early 1980s. Since then, hundreds of such genes have been discovered, and this "treasure trove," as Weinberg calls it, has led to many new drugs. Weinberg is also helping make sense of a vast amount of complex genetic information by finding global regulators of processes common to all cancers.

Technology Review talked with Weinberg about his research into one of these basic processes. Metastasis--the spread of cancer from its initial site to other places throughout the body--is responsible for 90 percent of cancer deaths. Weinberg suggests that preventive steps, such as taking vitamins, will be key to reducing cancer deaths.

Technology Review: How does metastasis work, and how are cancer stem cells involved?

Robert Weinberg: Until recently, most people--certainly myself--believed that all the cancer cells within a tumor were essentially equivalent to each other. But over the last three or four years, there's come increasing evidence that within solid tumors, as well as blood-born tumors, there is a hierarchy of cancer cells, with some cells being more important than others. A cancer stem cell is defined as a cell that, when plucked out of the tumor and introduced into a new host like a mouse, is able to spawn an entirely new tumor.

Cancer cells initially invade locally in the nearby tissue. Some cancer cells are able to invade into the circulation. They are then carried to distant sites within the body, [escape from circulation,] and invade into adjacent tissue. There they are able to survive and form what's called a micro-metastasis, which represents a tiny little colony of cancer cells which more often than not fails to develop into a tumor for a variety of reasons, not all of which we understand. On rare occasion, one of those disseminated micro-metastases may indeed figure out a way of growing into a macroscopic metastasis, and as such, it may for the first time create a life-threatening growth.

TR: What is it that allows these cells to form new tumors?

RW: It's now increasingly apparent that one mechanism, quite possibly the dominant mechanism, involves the ability by the cancer cell to resurrect early embryonic behavioral programs. [In the embryo, these programs] normally enable different tissues to form and depend on the ability of embryonic cells to move from one site in the body to another. This movement in the embryo is superficially similar to metastasis. The way cancer cells acquire this embryonic trait of being able to move throughout the organism depends on their ability to resurrect these early embryonic behavioral programs, which they do through their ability to induce the expression of early embryonic transcription factors [proteins that control the expression of a large number of genes]. In this case, these transcription factors control groups of genes that, when turned on, allow the cancer cells to move, to become invasive, to resist programmed cell death (which otherwise threatens their existence once they leave the primary tumor), and even to release degradative enzymes that break down the [surrounding tissue that] represents an impediment to the forward march of the cancer cells.

[1] 2 Next »

Comments

  • Embryological Cancer Cells
    ajimenez on 11/06/2007 at 9:48 AM
    Posts:
    14
    I believe that a single cure is possible. If the cancer cell reverts to an earlier embryological stage then there is a very good possibility that the cell's program could be "fast forwarded" to an adult phenotype. Perhaps something innocuous like connective tissue.

    I have had these ideas ever since the '70's when I heard about a woman biologist who put cancer cells into a developing embryo and then noticed that the cancerous state disappeared. For more details on this please see my blog: http://ortholex.blogspot.com
    Rate this comment: 12345
    • Re: Embryological Cancer Cells
      prime3end on 01/17/2008 at 6:30 PM
      Posts:
      2
      Its completely in line with Weinberg and others' work, many others. Telomerase switches 217 genes to cancer mode, turning on 76 genes associated with growth (Elizabeth Blackburn co discoverer of telomerase). It allows cells to overcome the hayflick limit, so achieving replicative immortality. Telomerase also turns on glycolysis in melanoma (and probably other cancers) per Mohammed Kashani-Sabet UCSF and Blackburn et al. He observed some normalization of melanoma cells when telomerase was inhibited, also cell death. Glycolysis is of course cancers monstrous energy source. When Evangelos Mikelakis at U of Alberta used sodium dichloroacetate to treat human breast brain and lung cancer in rats, he saw 70% tumor reduction in 3 weeks. He was stopping glycolysis. Now imagine effective telomerase inhibition with an additional direct attack on glycolysis. Close monitoring would be required to limit tumor lysis syndrome,,, which is too many cells dying to fast for the body to purge/process them. Feel free to contact me for links to the work I cite if you are a researcher or doc. I'm not selling anything. Also in todays news, several cancer causing viruses were studied and it was found that they actively hijack telomerase production to magnify their own numbers, providing growth in otherwise senescent cells. The paper continues that this growth allows for further mutations in ,, well perhaps in Weinbergs other two genes he uses to cause cancer in "many human cell types", a tumor suppressor gene and an oncogene. Telomerase is the first step in tumorogenisis. A cancer and an embryo are more like each other, than like a normal cell. prime3end@yahoo.com www.geocities.com/prime3end
      Rate this comment: 12345
  • regarding comment
    rhansing on 11/06/2007 at 11:22 AM
    Posts:
    11
    Avg Rating:
    4/5
    a few cancers are composed of diploid cells, but most have an abnormal triploidy as well as chromosome malarrangement;hance, to regress when injected into an embyro, and revert to normal seems moot.how do we know that the cancer cells did not take hold and died? were the cancer cell labled with a tag, to determine that they actually reverted to normal.

    regardless, as crazy as it sounds, maybe the reseach has merit. there are many lessons in the history of science where cockeyed ideas eventually were proven true. think, the cloning of dolly, the dogma was that it couldn't be done.

    to me one of the greatest hinderance to the progress of science is the hiarchical funding (which is blinded by conventional wisdom) of research. Those with the creative ideas never get a chance to explore their "crazy" ideas.

    ron hansing


    Rate this comment: 12345
    • Re: regarding comment
      prime3end on 01/17/2008 at 6:39 PM
      Posts:
      2
      Funding yes, was it Otto Warburg who first observed the similar growth rates of an embryo and a tumor, and that they both appeared to run on glycolysis?  How very long ago was that.  How I wish there was no church lady in the laboratory or fuding considerations.  But as you say, there is a heirarchy to deal with too.  Politics of one type or another, while 580,000 die per year and a similar number maimed by today's "treatments".
      Rate this comment: 12345
Advertisement

Current Issue

Technology Review November/December 2008
Sun + Water = Fuel
An MIT chemist has opened the way to making hydrogen fuel from water using sunlight.
•  Subscribe
Save 41%
•  Table of Contents
•  MIT News

Magazine Services

Career Resources

MIT Technology Insider

Stories and breaking news from inside MIT about the latest research, innovations, and startups--in a convenient monthly e-newsletter. Subscribe today

Follow us on Twitter

Twitter

Get Technology Review updates via the web, cellphone, or Instant Messager – Follow techreview on Twitter!

Advertisement
Advertisement
Advertisement
TECHNOLOGY RESOURCES
Advertisement
MIT Massachusetts Institute of Technology